Biotechnology
Medical
Biopharmaceutical

PTC Therapeutics

$37.53
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.18 (-0.48%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell PTCT and other stocks, options, ETFs, and crypto commission-free!

About

PTC Therapeutics, Inc. Common Stock, also called PTC Therapeutics, is a biopharmaceutical company, which engages in the discovery and commercialization of clinically-differentiated medicines. Read More It focuses on the development of new treatments for multiple therapeutic areas, including rare diseases and oncology. The company was founded by Allan Steven Jacobson and Stuart W. Peltz on March 31, 1998 and is headquartered in South Plainfield, NJ.

Employees
517
Headquarters
South Plainfield, New Jersey
Founded
1998
Market Cap
1.91B
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
969.25K
High Today
$38.09
Low Today
$37.04
Open Price
$37.75
Volume
191.19K
52 Week High
$52.95
52 Week Low
$24.60

Collections

Biotechnology
Medical
Biopharmaceutical
Pharmaceutical
Health
Therapy
2013 IPO

News

Yahoo FinanceMar 16

Edited Transcript of PTCT earnings conference call or presentation 28-Feb-19 9:30pm GMT

Q4 2018 PTC Therapeutics Inc Earnings Call South Plainfield Mar 16, 2019 (Thomson StreetEvents) -- Edited Transcript of PTC Therapeutics Inc earnings conference call or presentation Thursday, February 28, 2019 at 9:30:00pm GMT TEXT version of Transcript ================================================================================ Corporate Participants ================================================================================ * Christine Utter PTC Therapeutics, Inc. - Principal Financial Off...

23
Yahoo FinanceMar 15

Is PTC Therapeutics, Inc.’s (NASDAQ:PTCT) Balance Sheet Strong Enough To Weather A Storm?

Small and large cap stocks are widely popular for a variety of reasons, however, mid-cap companies such as PTC Therapeutics, Inc.

15
Simply Wall StMar 12

Shareholders Are Raving About How The Therapeutics (NASDAQ:PTCT) Share Price Increased 515%

Generally speaking, investors are inspired to be stock pickers by the potential to find the big winners. Not every pick can be a winner, but when you pick the right stock, you can win big. One such superstar is PTC Therapeutics, Inc. (NASDAQ:PTCT), which saw its share price soar 515% in three years. In more good news, the share price has risen -0.5% in thirty days. We note that Therapeutics reported its financial results recently; luckily, you can catch up on the latest revenue and profit numbers in our com...

29

Earnings

-$1.30
-$0.86
-$0.41
$0.03
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
Actual
Expected May 9, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.